Coloplast Future Growth
Future criteria checks 2/6
Coloplast is forecast to grow earnings and revenue by 12.5% and 8.3% per annum respectively. EPS is expected to grow by 12.5% per annum. Return on equity is forecast to be 32.5% in 3 years.
Key information
12.5%
Earnings growth rate
12.5%
EPS growth rate
| Medical Equipment earnings growth | 18.1% |
| Revenue growth rate | 8.3% |
| Future return on equity | 32.5% |
| Analyst coverage | Good |
| Last updated | 25 Jun 2024 |
Recent future growth updates
Recent updates
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Apr 26There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price
Apr 08Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Jan 09Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings
Dec 22These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Sep 30Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price
Jun 10Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 01These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 14Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 26Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 11With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case
Oct 25Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)
Aug 26These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jul 27Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching
Jul 12Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?
May 23Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00
May 08Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly
Apr 13Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock
Mar 29Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 12Coloplast (CPH:COLO B) Could Easily Take On More Debt
Jan 12Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?
Dec 28Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All
Nov 25A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Oct 31Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly
Oct 02Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?
Sep 16Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?
Aug 02Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Jul 01Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?
Jun 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2026 | 31,801 | 6,908 | 6,676 | 8,129 | 17 |
| 9/30/2025 | 29,342 | 6,108 | 6,042 | 7,351 | 19 |
| 9/30/2024 | 27,018 | 5,239 | 4,339 | 4,711 | 19 |
| 3/31/2024 | 25,526 | 4,965 | 1,053 | 2,278 | N/A |
| 12/31/2023 | 25,001 | 4,868 | 4,285 | 5,527 | N/A |
| 9/30/2023 | 24,500 | 4,783 | 2,985 | 4,226 | N/A |
| 6/30/2023 | 24,333 | 4,784 | 3,226 | 4,485 | N/A |
| 3/31/2023 | 24,074 | 4,801 | 3,663 | 4,894 | N/A |
| 12/31/2022 | 23,515 | 4,626 | 3,246 | 4,455 | N/A |
| 9/30/2022 | 22,579 | 4,706 | 3,964 | 5,099 | N/A |
| 6/30/2022 | 21,620 | 4,781 | 3,894 | 4,913 | N/A |
| 3/31/2022 | 20,606 | 4,746 | 3,735 | 4,712 | N/A |
| 12/31/2021 | 19,857 | 4,896 | 4,272 | 5,209 | N/A |
| 9/30/2021 | 19,426 | 4,825 | 3,324 | 5,290 | N/A |
| 6/30/2021 | 18,916 | 4,561 | 3,102 | 5,023 | N/A |
| 3/31/2021 | 18,500 | 4,304 | 3,162 | 5,077 | N/A |
| 12/31/2020 | 18,570 | 4,241 | 3,003 | 4,941 | N/A |
| 9/30/2020 | 18,544 | 4,197 | 3,828 | 4,759 | N/A |
| 6/30/2020 | 18,572 | 3,949 | 3,876 | 4,842 | N/A |
| 3/31/2020 | 18,752 | 4,020 | 3,872 | 4,764 | N/A |
| 12/31/2019 | 18,330 | 3,974 | 3,833 | 4,615 | N/A |
| 9/30/2019 | 17,939 | 3,873 | 3,667 | 4,357 | N/A |
| 6/30/2019 | 17,555 | 4,119 | 3,599 | 4,161 | N/A |
| 3/31/2019 | 17,181 | 3,999 | 3,562 | 4,177 | N/A |
| 12/31/2018 | 16,815 | 3,896 | 3,522 | 4,126 | N/A |
| 9/30/2018 | 16,449 | 3,845 | 3,692 | 4,361 | N/A |
| 6/30/2018 | 16,195 | 3,816 | 3,587 | 4,370 | N/A |
| 3/31/2018 | 15,882 | 3,778 | 3,361 | 4,111 | N/A |
| 12/31/2017 | 15,728 | 3,791 | N/A | 4,004 | N/A |
| 9/30/2017 | 15,528 | 3,797 | N/A | 3,251 | N/A |
| 6/30/2017 | 15,287 | 3,211 | N/A | 2,994 | N/A |
| 3/31/2017 | 15,061 | 3,279 | N/A | 2,492 | N/A |
| 12/31/2016 | 14,780 | 3,264 | N/A | 2,653 | N/A |
| 9/30/2016 | 14,681 | 3,143 | N/A | 3,028 | N/A |
| 6/30/2016 | 14,563 | 1,297 | N/A | 3,081 | N/A |
| 3/31/2016 | 14,417 | 1,028 | N/A | 3,568 | N/A |
| 12/31/2015 | 14,264 | 927 | N/A | 3,320 | N/A |
| 9/30/2015 | 13,909 | 899 | N/A | 3,337 | N/A |
| 6/30/2015 | 13,502 | 3,162 | N/A | 3,119 | N/A |
| 3/31/2015 | 13,096 | 3,241 | N/A | 3,015 | N/A |
| 12/31/2014 | 12,666 | 2,407 | N/A | 3,193 | N/A |
| 9/30/2014 | 12,428 | 2,390 | N/A | 3,149 | N/A |
| 6/30/2014 | 12,184 | 2,298 | N/A | 3,177 | N/A |
| 3/31/2014 | 12,008 | 2,220 | N/A | 3,074 | N/A |
| 12/31/2013 | 11,833 | 2,874 | N/A | 3,270 | N/A |
| 9/30/2013 | 11,635 | 2,711 | N/A | 3,136 | N/A |
| 6/30/2013 | 11,514 | 2,570 | N/A | 2,912 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COLO B's forecast earnings growth (12.5% per year) is above the savings rate (0.9%).
Earnings vs Market: COLO B's earnings (12.5% per year) are forecast to grow slower than the Danish market (13% per year).
High Growth Earnings: COLO B's earnings are forecast to grow, but not significantly.
Revenue vs Market: COLO B's revenue (8.3% per year) is forecast to grow slower than the Danish market (11.3% per year).
High Growth Revenue: COLO B's revenue (8.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: COLO B's Return on Equity is forecast to be high in 3 years time (32.5%)